Search

Dagmar E Meissner

from Bedford, MA
Age ~59
Get Report
Also known as:
Dagmar Missner
Phone and address:
74 Sweetwater Ave, Bedford, MA 01730
(781) 275-7164
Connected to:
Alex B Meissner, 34Alexandra H Meissner, 51Alfred E Meissner, 69Curt A Meissner, 55Denise L Meissner, 58Elvira Meissner, 64Erik K Meissner, 62Gerhard W Meissner, 88Horst W Meissner, 77Jackie Meissner, 40

Dagmar Meissner Phones & Addresses

  • 74 Sweetwater Ave, Bedford, MA 01730 (781) 275-7164
  • 1661 Beryl St, San Diego, CA 92109
  • 3966 Haines St, San Diego, CA 92109 (858) 483-4830
  • Somerville, MA
  • Cardiff by the Sea, CA
  • Encinitas, CA
  • 11353 Ocean Ridge Way, San Diego, CA 92130

Work

Company: San diego bioprocess forum Jan 2011 to 2014 Position: President and co-organizer

Education

Degree: Master of Science, Masters School / High School: Tufts University 1990 to 1992 Specialities: Chemical Engineering

Skills

Technology Transfer • Gmp • Biotechnology • Purification • Validation • Protein Chemistry • Biopharmaceuticals • Life Sciences

Languages

French • German

Interests

Photography

Industries

Biotechnology

Resumes

Resumes

Dagmar Meissner Photo 1

President

View page
Location:
Bedford, MA
Industry:
Biotechnology
Work:
San Diego Bioprocess Forum Jan 2011 - 2014
President and Co-Organizer
Bioprocess Solutions Jan 2011 - 2014
President
Microislet 2006 - 2007
Director Preclinical Development
Microislet 2001 - 2005
Director Process R and D
Cp Kelco 1998 - 2000
Senior Scientist, Process R and D
Education:
Tufts University 1990 - 1992
Master of Science, Masters, Chemical Engineering Hochschule Mannheim 1984 - 1989
Skills:
Technology Transfer
Gmp
Biotechnology
Purification
Validation
Protein Chemistry
Biopharmaceuticals
Life Sciences
Interests:
Photography
Languages:
French
German

Business Records

Name / Title
Company / Classification
Phones & Addresses
Dagmar Meissner
CTO
MicroIslet, Inc.
Commercial Physical and Biological Research
6370 Nancy Ridge Dr Ste 112, San Diego, CA 92121
Dagmar Meissner
Bioprocess Solutions LLC
Consulting In The Area of Bioprocess Dev · Nonclassifiable Establishments
11353 Ocean Rdg Way, San Diego, CA 92130
Dagmar Meissner
CTO
MICROISLET, INC
Commercial Physical Research
6357 Nancy Rdg Dr SUITE 112, San Diego, CA 92121
6370 Nancy Rdg Dr, San Diego, CA 92121
(858) 657-0287
Dagmar Meissner
CTO
MicroIslet, Inc.
Commercial Physical and Biological Research
6370 Nancy Ridge Dr Ste 112, San Diego, CA 92121

Publications

Us Patents

Clarification Of Sphingans And Compositions Thereof

View page
US Patent:
7887866, Feb 15, 2011
Filed:
Mar 2, 2001
Appl. No.:
09/798642
Inventors:
Stan Bower - La Jolla CA, US
Ellen Burke - San Diego CA, US
Nancy E. Harding - San Diego CA, US
Yamini N. Patel - San Diego CA, US
J. Carrie Schneider - San Diego CA, US
Dagmar Meissner - San Diego CA, US
Neil A. Morrison - San Diego CA, US
Ralph Bezanson - Alpine CA, US
Assignee:
CP Kelco U.S., Inc. - Atlanta GA
International Classification:
A23L 1/054
US Classification:
426573, 426271
Abstract:
The invention relates to mutant strains of the genus which have a mutation in at least one gene encoding a protein involved in polyhydroxybutyrate (“PHB”) synthesis that allows the mutant strains to produce PHB-deficient sphingans. The invention is also directed to a process for preparing a clarified sphingan solution comprising heating aqueous sphingan solution, in particular PHB-deficient sphingan solution, to a clarification temperature of about 30 C. to about 70 C. , and treating the solution with a clarification agent and enzymes. In addition, the invention is directed to a food or industrial product comprising a PHB-deficient and/or clarified sphingan. One particular embodiment of the invention is directed to a clarified, PHB-deficient high-acyl gellan and the processes of making thereof.

Mutant Bacterial Strains Of The Genus Sphingomonas Deficient In Production Of Polyhydroxybutyrate And A Process Of Clarification Of Sphingans And Compositions Thereof

View page
US Patent:
8198064, Jun 12, 2012
Filed:
Dec 2, 2005
Appl. No.:
11/292366
Inventors:
Stan Bower - La Jolla CA, US
Ellen Burke - San Diego CA, US
Nancy E. Harding - San Diego CA, US
Yamini N. Patel - San Diego CA, US
J. Carrie Schneider - San Diego CA, US
Dagmar Meissner - San Diego CA, US
Neil A. Morrison - San Diego CA, US
Ralph Bezanson - Alpine CA, US
Assignee:
CP Kelco U.S., Inc. - Atlanta GA
International Classification:
C12N 1/12
C12N 15/00
C12N 9/10
C07H 21/02
C07H 21/04
US Classification:
4352521, 435440, 435193, 536 231, 536 232
Abstract:
The invention relates to mutant strains of the genus which have a mutation in at least one gene encoding a protein involved in polyhydroxybutyrate (“PHB”) synthesis that allows the mutant strains to produce PHB-deficient sphingans. The invention is also directed to a process for preparing a clarified sphingan solution comprising heating aqueous sphingan solution, in particular PHB-deficient sphingan solution, to a clarification temperature of about 30 C. to about 70 C. , and treating the solution with a clarification agent and enzymes. In addition, the invention is directed to a food or industrial product comprising a PHB-deficient and/or clarified sphingan. One particular embodiment of the invention is directed to a clarified, PHB-deficient high-acyl gellan and the processes of making thereof.

Production Of Multivesicular Liposomes

View page
US Patent:
20020039596, Apr 4, 2002
Filed:
Nov 13, 1998
Appl. No.:
09/192064
Inventors:
HARTOUN HARTOUNIAN - SAN DIEGO CA, US
DAGMAR MEISSNER - CARDIFF CA, US
CLINT B. PEPPER - OCEANSIDE CA, US
International Classification:
A61K009/127
US Classification:
424/450000
Abstract:
Multivesicular liposomes are prepared at commercial scales by combining a first w/o emulsion with a second aqueous solution to form a w/o/w emulsion using a static mixer. Solvent is removed from the resulting emulsion to form multivesicular liposome-containing compositions. Further optional process steps include primary filtration and secondary cross-flow filtration. The products produced according to the processes of the invention can be produced through a series of aseptic steps.

Bead Embedded Cells

View page
US Patent:
20050147595, Jul 7, 2005
Filed:
Sep 14, 2004
Appl. No.:
10/941548
Inventors:
Dagmar Meissner - San Diego CA, US
Ingrid Stuiver - San Diego CA, US
International Classification:
A61K045/00
A61K009/16
A61K009/50
US Classification:
424093700, 424493000
Abstract:
A composition of beads formed from biologically compatible material and which hold comprise biologically active moieties. A method of treating of treating isolated biological moieties in culture media, embedding the moieties in biologically compatible material which does not incorporate adventitious excipients. A method of treating individuals in need of transplantation, which involves transplanting to the individual a composition which comprises a sufficient amount of beads.

Production Of Multivesicular Liposomes

View page
US Patent:
20070235889, Oct 11, 2007
Filed:
Feb 25, 2007
Appl. No.:
11/678615
Inventors:
Hartoun HARTOUNIAN - San Diego CA, US
Dagmar Meissner - Cardiff CA, US
Clint Pepper - Oceanside CA, US
Assignee:
SkyePharma, Inc. - San Diego CA
International Classification:
B01J 13/06
US Classification:
264004100
Abstract:
Multivesicular liposomes are prepared at commercial scales by combining a first w/o emulsion with a second aqueous solution to form a w/o/w emulsion using a static mixer. Solvent is removed from the resulting emulsion to form multivesicular liposome-containing compositions. Further optional process steps include primary filtration and secondary cross-flow filtration. The products produced according to the processes of the invention can be produced through a series of aseptic steps.

Mutant Bacterial Strains Of The Genus Sphingomonas Deficient In Production Of Polyhydroxybutyrate And A Process Of Clarification Of Sphingans And Compositions Thereof

View page
US Patent:
20080268527, Oct 30, 2008
Filed:
Dec 2, 2005
Appl. No.:
11/292356
Inventors:
Stan Bower - La Jolla CA, US
Ellen Burke - San Diego CA, US
Nancy E. Harding - San Diego CA, US
Yamini N. Patel - San Diego CA, US
J. Carrie Schneider - San Diego CA, US
Dagmar Meissner - San Diego CA, US
Neil A. Morrison - San Diego CA, US
Ralph Bezanson - Alpine CA, US
Assignee:
C.P. Kelco U.S., Inc. - Wilmington DE
International Classification:
C08B 37/00
US Classification:
435274
Abstract:
The invention relates to mutant strains of the genus which have a mutation in at least one gene encoding a protein involved in polyhydroxybutyrate (“PHB”) synthesis that allows the mutant strains to produce PHB-deficient sphingans. The invention is also directed to a process for preparing a clarified sphingan solution comprising heating aqueous sphingan solution, in particular PHB-deficient sphingan solution, to a clarification temperature of about 30 C. to about 70 C., and treating the solution with a clarification agent and enzymes. In addition, the invention is directed to a food or industrial product comprising a PHB-deficient and/or clarified sphingan. One particular embodiment of the invention is directed to a clarified, PHB-deficient high-acyl gellan and the processes of making thereof.

Production Of Multivesicular Liposomes

View page
US Patent:
20140004173, Jan 2, 2014
Filed:
Mar 8, 2013
Appl. No.:
13/791302
Inventors:
Dagmar Meissner - Cardiff CA, US
Clint B. Pepper - Oceanside CA, US
Assignee:
Pacira Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 9/127
A61K 31/7036
A61K 38/30
A61K 31/439
A61K 31/7068
US Classification:
424450, 514282, 514 49, 514 86, 514 40
Abstract:
Multivesicular liposomes are prepared at commercial scales by combining a first w/o emulsion with a second aqueous solution to form a w/o/w emulsion using a static mixer. Solvent is removed from the resulting emulsion to form multivesicular liposome-containing compositions. Further optional process steps include primary filtration and secondary cross-flow filtration. The products produced according to the processes of the invention can be produced through a series of aseptic steps.

Mutant Bacterial Strains Of The Genus Sphingomonas Deficient In Production Of Polyhydroxybutyrate And A Process Of Clarification Of Sphingans And Compositions Thereof

View page
US Patent:
20160176990, Jun 23, 2016
Filed:
Mar 4, 2016
Appl. No.:
15/060780
Inventors:
- Atlanta GA, US
Ellen Burke - San Diego CA, US
Nancy E. Harding - San Diego CA, US
Yamini N. Patel - San Diego CA, US
J. Carrie Schneider - San Diego CA, US
Dagmar Meissner - San Diego CA, US
Neil A. Morrison - San Diego CA, US
Ralph Bezanson - Alpine CA, US
International Classification:
C08B 37/00
C12P 19/04
C12N 1/20
Abstract:
The invention relates to mutant strains of the genus which have a mutation in at least one gene encoding a protein involved in polyhydroxybutyrate (“PHB”) synthesis that allows the mutant strains to produce PHB-deficient Sphingans. The invention is also directed to a process for preparing a clarified Sphingan solution comprising heating aqueous Sphingan solution, in particular PHB-deficient Sphingan solution, to a clarification temperature of about 30 C. to about 70 C., and treating the solution with a clarification agent and enzymes. In addition, the invention is directed to a food or industrial product comprising a PHB-deficient and/or clarified Sphingan. One particular embodiment of the invention is directed to a clarified, PHB-deficient high-acyl gellan and the processes of making thereof.
Control profile
Dagmar E Meissner from Bedford, MA, age ~59 Get Report